Preoperative neo-adjuvant therapy for curable rectal cancer - Reaching a consensus 2008

Colorectal Disease

Volumn 11, Issue 3, 2009, Pages 245-248

  Scott, Nigel A ^a   Susnerwala, S ^b   Gollins, S ^c   Sun Myint, A ^d   Levine, E ^e  

^a ROYAL PRESTON HOSPITAL   (United Kingdom)

^b Department of Clinical Oncology   (United Kingdom)

^c GLAN CLWYD HOSPITAL   (United Kingdom)

^d CLATTERBRIDGE CENTRE FOR ONCOLOGY   (United Kingdom)

^e CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Consensus; Neo adjuvant therapy; Rectal cancer

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; CONSENSUS DEVELOPMENT; EVIDENCE BASED PRACTICE; HUMAN; INTERDISCIPLINARY COMMUNICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE CARE; PRIORITY JOURNAL; RECTUM CANCER; REVIEW; TREATMENT DURATION; TREATMENT INDICATION; UNITED KINGDOM;

BIOPSY, NEEDLE; CHEMOTHERAPY, ADJUVANT; COLECTOMY; COMBINED MODALITY THERAPY; FEMALE; GREAT BRITAIN; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREOPERATIVE CARE; PROGNOSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 60549110902     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2008.01636.x     Document Type: Review

References (26)

1. MRC Working Party-Second Report. The evaluation of low dose preoperative X-ray therapy in the management of operable rectal cancer. Br J Surg 1984; 71: 21-5.
2. Fisher B, Wolmark N, Rockette H et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: Results from NSABP protocol R-01. J Natl Cancer Inst 1988; 80: 21-9.
3. MRC Rectal Cancer Working Party. Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Lancet 1996; 348: 1605-10.
4. Medical Research Council Rectal Cancer Working Party. Randomised trial of surgery alone versus surgery followed by radiotherapy for mobile cancer of the rectum. Lancet 1996; 348: 1610-4.
5. Swedish Rectal Cancer Trial. Improved survival with pre-operative radiotherapy in resectable rectal cancer. N Engl J Med 1997; 336: 890-987.
6. Martling A, Holm T, Rutqvist LE, Johansson H, Moran BJ, Heald RJ, Cedermark B. Impact of a surgical training programme on rectal cancer outcomes in Stockholm. Br J Surg 2005; 92 (2): 225-9.
7. Kapiteijn E, Marijnen CA, Nagtegaal ID et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345 (9): 638-46.
8. Peeters KCMJ, Marijnen CAM, Nagtegaal ID et al. The TME trial after a median follow-up of 6years: Increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007; 246: 693-701.
9. Nagtegaal ID, van de Velde CJH, Marijnen CAM, van Krieken JHJM, Quirke P. Low rectal cancer: A call for change in approach in abdominoperineal resection. J Clin Oncol 2005; 23: 9257-64.
10. Marijnen CAM, Nagtegaal ID, Kapiteijn E, Klein Kranenbarg E, Noordijk EM, van Krieken JHJM, van de Velde CJH, Co-operative Investigators of the Dutch Colorectal Cancer Group. Radiotherapy does not compensate for positive resection margins in rectal cancer patients: Report of a multicenter randomized trial. Int J Radiat Oncol Biol Phys 2003; 55: 1311-20.
11. David Sebag-Montefiore on behalf of the CR07 trial investigators, trial management group and the UKNCRI colorectal cancer study group. http://clients.mediaondemand.net/AssociationofColoproctology/2006/www/ player.html. (accessed 23 rd July 2008).
12. Peeters KCMJ, van de Velde CJH, Leer JWH et al. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: Increased bowel dysfunction in irradiated patients - a Dutch colorectal cancer group study. J Clin Oncol 2005; 23: 6199-206.
13. Pietrzak L, Bujko K, Nowacki MP et al. Quality of life, anorectal and sexual functions after preoperative radiotherapy for rectal cancer: report of a randomised trial. Radiat Oncol 2007; 84: 217-25.
14. Bosset JF, Calais G, Mineur L et al. Enhanced tumourocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results -EORTC 22921. J Clin Oncol 2005; 23: 5620-7.
15. Hartley A, Ho KF, McConkey C, Geh JI. Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: Analysis of phase II/III trials. Br J Radiol 2005; 78: 934-8.
16. Glynne-Jones R, Anyamene N. Just how useful an endpoint is complete pathological response after neoadjuvant chemoradiation in rectal cancer? Int J Radiat Oncol Biol Phys 2006; 66: 319-20.
17. Chau I, Brown G, Cunningham D et al. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. J Clin Oncol 2006; 24: 668-74.
18. Bujko K, Nowacki MP, Nasierowska-Guttmejer A et al. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006; 93: 1215-23.
19. Bosset JF, Collette L, Calais G et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006; 355: 1114-23.
20. Gérard J-P, Conroy T, Bonnetain F et al. Radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 2006; 24: 4620-5.
21. Sauer R, Becker H, Hohenberger W et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-40.
22. Wong RK, Tandan V, De Silva S et al. Preoperative radiotherapy and curative surgery for the management of localized rectal carcinoma. Cochrane Database Syst Rev 2007; 2: CD002102.
23. Glynne-Jones R, Harrison M. Locally advanced rectal cancer: What is the evidence for induction chemoradiation? Oncologist 2007; 12 (11): 1309-18.
24. Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986; 1 (8496): 1479-82.
25. Mercury Study Group. Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: Results of the MERCURY study. Radiology 2007; 243 (1): 132-9.
26. Radu C, Berglund A, Pahlman L, Glimelius B. Short-course preoperative radiotherapy with delayed surgery in rectal cancer - a retrospective study. Radiother Oncol 2008; 87 (3): 343-9.